Who are Sodium chlorure 0,9 %'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Plegisol In Plastic Container, Chlorure de sodium 0.9%, Normal Saline 0.9% Infusion Solution Bag, Plasma-lyte (static group), saline serum, NaCl 9% isotonic.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-chlorure-0-9.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Sodium chlorure 0,9 % — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sodium chlorure 0,9 % (Sodium chlorure 0,9 %) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte replacement solution. Area: Supportive Care.

phase 3 Electrolyte replacement solution Supportive Care Small molecule Live · refreshed every 30 min

Target snapshot

Sodium chlorure 0,9 % (Sodium chlorure 0,9 %) — University Hospital, Rouen. Sodium chloride 0.9% is an isotonic saline solution that replaces fluid and electrolytes to maintain osmotic balance and hydration.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Sodium chlorure 0,9 % TARGET	Sodium chlorure 0,9 %	University Hospital, Rouen	phase 3	Electrolyte replacement solution
Plegisol In Plastic Container	Calcium Chloride	Pfizer	marketed	Electrolyte replacement solution	Electrolyte balance and fluid homeostasis	1971-01-01
Chlorure de sodium 0.9%	Chlorure de sodium 0.9%	Centre Hospitalier Universitaire Dijon	marketed	Electrolyte replacement solution
Normal Saline 0.9% Infusion Solution Bag	Normal Saline 0.9% Infusion Solution Bag	Vanderbilt University Medical Center	marketed	Crystalloid fluid / Electrolyte replacement solution
Plasma-lyte (static group)	Plasma-lyte (static group)	Algemeen Ziekenhuis Maria Middelares	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution
saline serum	saline serum	Hédi Chaker Hospital	marketed	Crystalloid fluid / Electrolyte replacement solution
NaCl 9% isotonic	NaCl 9% isotonic	Centre Hospitalier Universitaire de Nice	marketed	Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte replacement solution class)

Baxter Healthcare Corporation · 1 drug in this class
Centre Hospitalier Universitaire Dijon · 1 drug in this class
Centre Hospitalier Universitaire de Nice · 1 drug in this class
Department of Medical Services Ministry of Public Health of Thailand · 1 drug in this class
Federico II University · 1 drug in this class
Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
Nepal Health Research Council · 1 drug in this class
Pfizer · 1 drug in this class
Shanghai Hengrui Pharmaceutical Co., Ltd. · 1 drug in this class
TC Erciyes University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sodium chlorure 0,9 % — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-chlorure-0-9. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab